Explore the categories so you can find more about your search.

Categorie > Schizophrenia

Invega® Significantly Reduced Symptoms Of Schizophrenia In Acutely Ill, Hospitalised Patients Compared To Quetiapine

Categorie : Schizophrenia
Yesterday, Janssen-Cilag presented for the first time in Europe, new preliminary data that show acutely ill, hospitalised patients with schizophrenia experienced significant improvement in symptoms after taking INVEGA® (paliperidone prolonged-release tablets) as compared to Seroquel ...

read more Yesterday, Janssen-Cilag presented for the first time in Europe, new preliminary data that show acutely ill, hospitalised patients with schizophrenia experienced significant improvement in symptoms after taking INVEGA® (paliperidone prolonged-release tablets) as compared to Seroquel read more Sun Oct 2007 Sun Oct 2007

Forest Laboratories, Inc. And Gedeon Richter Announce Results Of Phase II-B Study For RGH-188 As A Treatment For Schizophrenia

Categorie : Schizophrenia
Forest Laboratories, Inc. (NYSE: FRX) and Gedeon Richter announced preliminary top-line results from a U.S. conducted randomized, double-blind, three-arm placebo-controlled study of RGH-188, a novel antipsychotic, in 389 schizophrenia patients. The protocol-specified primary ...

read more Forest Laboratories, Inc. (NYSE: FRX) and Gedeon Richter announced preliminary top-line results from a U.S. conducted randomized, double-blind, three-arm placebo-controlled study of RGH-188, a novel antipsychotic, in 389 schizophrenia patients. The protocol-specified primary read more Sun Oct 2007 Sun Oct 2007

Efficacy And Safety Of Aripiprazole As Adjunctive Therapy In Major Depressive Disorder

Categorie : Schizophrenia
In adults with major depressive disorder, adding aripiprazole to antidepressant therapy (ADT) resulted in significant improvement in the primary endpoint, the Montgomery-Asberg Depression Rating Scale (MADRS) Total Score. In this six-week, randomized, placebo-controlled study presented here at the 1 ...

read more In adults with major depressive disorder, adding aripiprazole to antidepressant therapy (ADT) resulted in significant improvement in the primary endpoint, the Montgomery-Asberg Depression Rating Scale (MADRS) Total Score. In this six-week, randomized, placebo-controlled study presented here at the 1 read more Tue May 2007 Tue May 2007

Royal Pharmaceutical Society Of Great Britain Advises On Counterfeit Zyprexa, UK

Categorie : Schizophrenia
Following the recall by the Medicines and Healthcare Products Regulatory Agency (MHRA) of Zyprexa batch numbers A200127, A216454, and A229505, which have been confirmed as counterfeit, the Royal Pharmaceutical Society of Great Britain (RPSGB) advises pharmacists to check their stock and to consult c ...

read more Following the recall by the Medicines and Healthcare Products Regulatory Agency (MHRA) of Zyprexa batch numbers A200127, A216454, and A229505, which have been confirmed as counterfeit, the Royal Pharmaceutical Society of Great Britain (RPSGB) advises pharmacists to check their stock and to consult c read more Mon May 2007 Mon May 2007

Schizophrenia And Depression Symptoms In Mice Caused By Gene Malfunctions

Categorie : Schizophrenia
Researchers have demonstrated for the first time that malfunction of a gene that had been associated with schizophrenia and depression does indeed cause symptoms of those disorders. They said their findings in mice offer a possible animal model for developing treatments for schizophrenia and depress ...

read more Researchers have demonstrated for the first time that malfunction of a gene that had been associated with schizophrenia and depression does indeed cause symptoms of those disorders. They said their findings in mice offer a possible animal model for developing treatments for schizophrenia and depress read more Thu May 2007 Thu May 2007

INVEGA(R) Receives Positive Opinion From European Committee For Human Medicinal Products For Treatment Of Schizophrenia

Categorie : Schizophrenia
Janssen-Cilag International NV announced today that the Committee for Human Medicinal Products (CHMP) in the European Union, has granted a positive opinion recommending approval of INVEGA(R) (paliperidone prolonged release tablets). INVEGA(R) is a new, once-daily, prolonged release oral medication, ...

read more Janssen-Cilag International NV announced today that the Committee for Human Medicinal Products (CHMP) in the European Union, has granted a positive opinion recommending approval of INVEGA(R) (paliperidone prolonged release tablets). INVEGA(R) is a new, once-daily, prolonged release oral medication, read more Sat Apr 2007 Sat Apr 2007

FDA Approves New Dose Of RISPERDAL® CONSTA® For Schizophrenia Treatment

Categorie : Schizophrenia
The U.S. Food and Drug Administration (FDA) approved a 12.5 mg dose of RISPERDAL® CONSTA® [(risperidone) Long-Acting Injection] for the treatment of schizophrenia within specific patient populations, including those with renal and hepatic impairment. The new dose of RISPERDAL® CONSTA® will provide p ...

read more The U.S. Food and Drug Administration (FDA) approved a 12.5 mg dose of RISPERDAL® CONSTA® [(risperidone) Long-Acting Injection] for the treatment of schizophrenia within specific patient populations, including those with renal and hepatic impairment. The new dose of RISPERDAL® CONSTA® will provide p read more Mon Apr 2007 Mon Apr 2007

Safety Analyses Of Clinical Data For Bifeprunox In Patients With Schizophrenia

Categorie : Schizophrenia
Solvay Pharmaceuticals, Inc., Wyeth Pharmaceuticals, a division of Wyeth (NYSE:WYE), and Lundbeck A/S presented clinical study results on bifeprunox at an international medical congress this week. Safety analyses suggest bifeprunox, an investigational treatment for adult patients diagnosed with schi ...

read more Solvay Pharmaceuticals, Inc., Wyeth Pharmaceuticals, a division of Wyeth (NYSE:WYE), and Lundbeck A/S presented clinical study results on bifeprunox at an international medical congress this week. Safety analyses suggest bifeprunox, an investigational treatment for adult patients diagnosed with schi read more Fri Apr 2007 Fri Apr 2007

Columbia Announces $9.2M Expansion Of Lieber Center For Schizophrenia Research

Categorie : Schizophrenia
Columbia University Medical Center announces the expansion of its Lieber Center for Schizophrenia Research and the launch of a new comprehensive psychiatric care clinic at its East 60th Street location, all made possible through a $9.2 million gift from Stephen and Constance Lieber and the Essel Fou ...

read more Columbia University Medical Center announces the expansion of its Lieber Center for Schizophrenia Research and the launch of a new comprehensive psychiatric care clinic at its East 60th Street location, all made possible through a $9.2 million gift from Stephen and Constance Lieber and the Essel Fou read more Sun Apr 2007 Sun Apr 2007

Schizophrenia And Sex Differences In Emotional Processing

Categorie : Schizophrenia
Patients with schizophrenia are known to be impaired in several domains of emotional processing. These deficits have been associated with impaired social functioning. [click link for full article] ...

read more Patients with schizophrenia are known to be impaired in several domains of emotional processing. These deficits have been associated with impaired social functioning. [click link for full article] read more Tue Mar 2007 Tue Mar 2007

Eli Lilly's Zyprexa Will Remain The Clinical Gold Standard For The Treatment Of Schizophrenia Through 2015

Categorie : Schizophrenia
Decision Resources, Inc., one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that Eli Lilly's Zyprexa will remain the gold standard for the treatment of schizophrenia through 2015. [click link for full article] ...

read more Decision Resources, Inc., one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that Eli Lilly's Zyprexa will remain the gold standard for the treatment of schizophrenia through 2015. [click link for full article] read more Thu Mar 2007 Thu Mar 2007

Eli Lilly's Zyprexa Will Remain The Clinical Gold Standard For The Treatment Of Schizophrenia Through 2015

Categorie : Schizophrenia
Decision Resources, Inc., one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that Eli Lilly's Zyprexa will remain the gold standard for the treatment of schizophrenia through 2015. [click link for full article] ...

read more Decision Resources, Inc., one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that Eli Lilly's Zyprexa will remain the gold standard for the treatment of schizophrenia through 2015. [click link for full article] read more Thu Mar 2007 Thu Mar 2007

Possible Genetic Link To Schizophrenia, Alcoholism, Parkinson's Disease Identified

Categorie : Schizophrenia
Several neurological and psychiatric disorders, including schizophrenia, alcoholism, and Parkinson's disease, are associated with changes in the brain that affect the nerves that communicate with each other through the naturally-produced chemical dopamine. One protein that is crucial for dopamine-me ...

read more Several neurological and psychiatric disorders, including schizophrenia, alcoholism, and Parkinson's disease, are associated with changes in the brain that affect the nerves that communicate with each other through the naturally-produced chemical dopamine. One protein that is crucial for dopamine-me read more Sun Feb 2007 Sun Feb 2007

Brain's Reward Circuit Activity Ebbs And Flows With A Woman's Hormonal Cycle

Categorie : Schizophrenia
Fluctuations in sex hormone levels during women's menstrual cycles affect the responsiveness of their brains' reward circuitry, an imaging study at the National Institute of Mental Health (NIMH), a component of the National Institutes of Health (NIH), has revealed. While women were winning rewards, ...

read more Fluctuations in sex hormone levels during women's menstrual cycles affect the responsiveness of their brains' reward circuitry, an imaging study at the National Institute of Mental Health (NIMH), a component of the National Institutes of Health (NIH), has revealed. While women were winning rewards, read more Tue Feb 2007 Tue Feb 2007

Potential Breakthrough For Schizophrenia Treatment

Categorie : Schizophrenia
A team of Canadian researchers, lead by Dr. Susan George and Dr. Brian O'Dowd at the Centre for Addiction and Mental health (CAMH), discovered a distinct dopamine signalling complex in the brain. Composed of two different types of dopamine receptors, this novel target may have a significant role in ...

read more A team of Canadian researchers, lead by Dr. Susan George and Dr. Brian O'Dowd at the Centre for Addiction and Mental health (CAMH), discovered a distinct dopamine signalling complex in the brain. Composed of two different types of dopamine receptors, this novel target may have a significant role in read more Fri Jan 2007 Fri Jan 2007

First-Tme Mothers At Increased Risk For Postpartum Mental Disorders

Categorie : Schizophrenia
New mothers are at an increased risk for mental disorders such as schizophrenia, depression and bipolar disorder in the 3 months following the birth of their first child, according to a study in the December 6 issue of JAMA. The study also found that first-time fathers do not have an increased risk ...

read more New mothers are at an increased risk for mental disorders such as schizophrenia, depression and bipolar disorder in the 3 months following the birth of their first child, according to a study in the December 6 issue of JAMA. The study also found that first-time fathers do not have an increased risk read more Wed Dec 2006 Wed Dec 2006

Schizophrenia Treatment With Older, Generic Antipsychotics Cheaper, As Effective As Treatment With Newer Drugs

Categorie : Schizophrenia
Treating schizophrenia patients with older, less expensive antipsychotic drugs reduces overall treatment costs by up to 30% and produces no increase in side effects or decrease in effectiveness compared with newer, brand-name medications, according to a cost-effectiveness study published Friday in t ...

read more Treating schizophrenia patients with older, less expensive antipsychotic drugs reduces overall treatment costs by up to 30% and produces no increase in side effects or decrease in effectiveness compared with newer, brand-name medications, according to a cost-effectiveness study published Friday in t read more Tue Dec 2006 Tue Dec 2006

Hospital Admissions Halved And Cost Savings Made When People With Schizophrenia Switched To Risperdal (Reg) Consta (TM)

Categorie : Schizophrenia
New data presented today at the European College of Neuropsychopharmacology (ECNP) annual meeting, showed that a financial saving of £1528 could be made per patient per year as a result of prescribing Risperdal® Consta? (risperidone long-acting injection). [click link for full article] ...

read more New data presented today at the European College of Neuropsychopharmacology (ECNP) annual meeting, showed that a financial saving of £1528 could be made per patient per year as a result of prescribing Risperdal® Consta? (risperidone long-acting injection). [click link for full article] read more Wed Nov 2006 Wed Nov 2006

Hospital Admissions Halved And Cost Savings Made When People With Schizophrenia Switched To Risperdal® Consta?

Categorie : Schizophrenia
New data presented today at the European College of Neuropsychopharmacology (ECNP) annual meeting, showed that a financial saving of £1528 could be made per patient per year as a result of prescribing Risperdal® Consta? (risperidone long-acting injection). [click link for full article] ...

read more New data presented today at the European College of Neuropsychopharmacology (ECNP) annual meeting, showed that a financial saving of £1528 could be made per patient per year as a result of prescribing Risperdal® Consta? (risperidone long-acting injection). [click link for full article] read more Sat Sep 2006 Sat Sep 2006

Schizophrenia News from Medical News Today

Categorie : Schizophrenia
Latest Schizophrenia news updated throughout the day, every day ...

read more Latest Schizophrenia news updated throughout the day, every day read more Tue Aug 2006 Tue Aug 2006

<<< previous | 1 | 2 | 3 | 4 next >>>



     


Custom Search